Oppenheimer & Co. Inc. Buys 41,234 Shares of Oscar Health, Inc. $OSCR

Oppenheimer & Co. Inc. lifted its stake in Oscar Health, Inc. (NYSE:OSCR) by 150.7% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 68,596 shares of the company’s stock after buying an additional 41,234 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Oscar Health were worth $1,299,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the stock. Straightline Group LLC increased its holdings in Oscar Health by 3.7% in the 2nd quarter. Straightline Group LLC now owns 18,082 shares of the company’s stock valued at $388,000 after acquiring an additional 640 shares during the last quarter. Wealthspire Advisors LLC increased its holdings in shares of Oscar Health by 6.7% in the second quarter. Wealthspire Advisors LLC now owns 11,117 shares of the company’s stock worth $238,000 after purchasing an additional 700 shares during the last quarter. PNC Financial Services Group Inc. increased its holdings in shares of Oscar Health by 14.4% in the second quarter. PNC Financial Services Group Inc. now owns 7,140 shares of the company’s stock worth $153,000 after purchasing an additional 900 shares during the last quarter. Focus Partners Wealth lifted its position in shares of Oscar Health by 1.8% in the first quarter. Focus Partners Wealth now owns 55,158 shares of the company’s stock worth $723,000 after buying an additional 949 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its stake in Oscar Health by 71.4% during the second quarter. Nisa Investment Advisors LLC now owns 2,658 shares of the company’s stock valued at $57,000 after buying an additional 1,107 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on OSCR shares. Raymond James Financial upgraded Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price target for the company in a report on Thursday. Wells Fargo & Company cut their target price on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a report on Thursday, November 13th. Stephens initiated coverage on shares of Oscar Health in a research note on Thursday, December 11th. They set an “equal weight” rating and a $17.00 price target on the stock. Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a research note on Thursday, January 22nd. Finally, Wall Street Zen upgraded shares of Oscar Health from a “sell” rating to a “hold” rating in a report on Saturday. Two research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Oscar Health currently has a consensus rating of “Hold” and a consensus price target of $16.88.

Insider Activity

In other Oscar Health news, CFO Richard Scott Blackley sold 25,135 shares of the business’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $416,989.65. Following the completion of the transaction, the chief financial officer owned 1,351,034 shares in the company, valued at $22,413,654.06. The trade was a 1.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Mario Schlosser sold 23,038 shares of the stock in a transaction that occurred on Thursday, January 8th. The stock was sold at an average price of $17.65, for a total value of $406,620.70. Following the completion of the sale, the insider owned 350,180 shares in the company, valued at approximately $6,180,677. The trade was a 6.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 197,125 shares of company stock valued at $3,265,300. Company insiders own 24.39% of the company’s stock.

Oscar Health Stock Down 2.2%

Shares of OSCR opened at $13.41 on Friday. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.80. The company has a market cap of $3.55 billion, a PE ratio of -7.70 and a beta of 1.90. The business has a fifty day moving average of $15.24 and a 200 day moving average of $16.71.

Oscar Health (NYSE:OSCR) last announced its earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share for the quarter, missing the consensus estimate of ($0.92) by ($0.32). The firm had revenue of $2.76 billion during the quarter, compared to analysts’ expectations of $3.12 billion. Oscar Health had a negative net margin of 3.79% and a negative return on equity of 37.72%. The company’s revenue was up 17.3% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.62) EPS. On average, sell-side analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.